PANGENETICS
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases. PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employs a lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is currently being evaluated in a clinical study in psoriatic arthritis patients
PANGENETICS
Social Links:
Industry:
Pharmaceutical
Founded:
1995-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.pangenetics.com
Total Employee:
11+
Status:
Active
Contact:
+31302537911
Total Funding:
52.71 M USD
Technology used in webpage:
Amazon Amazon Ohio Region
Current Employees Featured
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series C - PanGenetics
Crédit Agricole
Crédit Agricole investment in Series C - PanGenetics
Index Ventures
Index Ventures investment in Series C - PanGenetics
Biogen Idec
Biogen Idec investment in Series C - PanGenetics
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity investment in Series C - PanGenetics
Crédit Agricole
Crédit Agricole investment in Series B - PanGenetics
Index Ventures
Index Ventures investment in Series B - PanGenetics
ABN AMRO Fund
ABN AMRO Fund investment in Series B - PanGenetics
Index Ventures
Index Ventures investment in Seed Round - PanGenetics
Official Site Inspections
http://www.pangenetics.com
- Host name: ec2-52-71-57-184.compute-1.amazonaws.com
- IP address: 52.71.57.184
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "PanGenetics"
PanGenetics - Products, Competitors, Financials, Employees ...
PanGenetics is a clinical development company that specializes in taking antibodies from the …See details»
PanGenetics BV Information - RocketReach
PanGenetics B.V., a therapeutic antibody development company, focuses on the development …See details»
PanGenetics BV Overview | SignalHire Company Profile
Organization Website. pangenetics.com . PanGenetics BV industries. Pharma ... PanGenetics …See details»
PanGenetics BV - VentureRadar
FF Pharma has exclusively licensed from PanGenetics BV all of the underlying IP to allow …See details»
PanGenetics BV - Utrecht, Netherlands - bionity.com
Nov 13, 2009 PanGenetics is headquartered in Utrecht, The Netherlands with an office near …See details»
Abbott Laboratories Acquires PanGenetics BV - Mergr
Nov 12, 2009 PanGenetics is headquartered in Utrecht, The Netherlands with an office near …See details»
PanGenetics - CoBee Company Profile & Funding Rounds
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated …See details»
PanGenetics BV - Drug pipelines, Patents, Clinical trials - Synapse
Explore PanGenetics BV with its drug pipeline, therapeutic area, technology platform, 1 news, …See details»
PanGenetics - Funding, Financials, Valuation & Investors
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated …See details»
PanGenetics company information, funding & investors
PanGenetics, monoclonal antibodies for the treatment of immune mediated diseases. Here …See details»
PanGenetics - Omnes Capital
Mar 28, 2006 SECTOR : Biotech ENTRY DATE : 2006 EXIT DATE : 2009 BUSINESS : …See details»
Pangenetics - Company Profile - Tracxn
Pangenetics - Limited information available. Raised a total funding of $50.7M over 2 rounds …See details»
PanGenetics - Contacts, Employees, Board Members, Advisors
Organization. PanGenetics . Connect to CRM . Save . Summary. Financials. People. …See details»
PanGenetics | Qodeo
View this profile now on qodeo. Valuation Valuations NowSee details»
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF …
Nov 12, 2009 Kevin Johnson, CEO of PanGenetics, commented: "We are very pleased to …See details»
PanGenetics gets $170M upfront for promising pain drug
Nov 12, 2009 The Dutch biotech PanGenetics has forged a $190 million licensing pact with …See details»
Organization | PanGenetics UK Limited
PanGenetics UK Limited Report issue. For profit Phase 1. Founded: Cambridge United …See details»
PanGenetics BV (PanGenetics BV) - 药物管线_专利_临床试验_投融 …
了解PanGenetics BV (PanGenetics BV)公司的药物管线，治疗领域，技术平台，以及它的2篇新 …See details»
PanGenetics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
PanGenetics uses 3 technology products and services including Google Analytics, Apache …See details»
Mendel’s Theory of Heredity | SpringerLink
Dec 29, 2024 6.1.1 Childhood and Education. The man (Fig. 6.1) who would later be …See details»